NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by ...

It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...

The new pill is seen as a ‘major leap forward’ for hundreds of patients living with the rarest forms of cystic fibrosis ...

Hundreds of children and adults in England with rare forms of cystic fibrosis will now be able to access a new triple-combinatio ...

When designing packaging, it’s easy to get carried away with the creative. You can occasionally forget who you’re really ...

Watch curator Edward J. Sullivan speak on the Colombian-born painter and detail what visitors will find at Americas Society's ...

Let’s prioritise function over form and people over polish. By doing so, we’ll not only create a more comfortable and conducive environment for worship, but we’ll also be serving the Ummah ...

Ono will assist with Vertex's clinical trials for povetacicept and handle marketing approvals in Japan and South Korea, focusing on IgAN and pMN with possible additional uses.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the European Commission approved the company’s new cystic fibrosis treatment, ALYFTREK ...

News North East News Northumberland Boy, 6, injured in hit-and-run crash with van in Northumberland The driver of the van – which is believed to be a silver Renault Master – did not stop to ...